Novartis's Gene Therapy Zolgensma Has Durable Effects At Five Years

Intrathecal Therapy's 'Remarkable' Disease Scores

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.